Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

2 articles from the last 90 days matching "Denmark"

ResearchBIORXIVMay 4

Preprint: Deep learning-based stratification of Schizophrenia Spectrum Disorder from real-world data reveals distinct profiles of common and rare variant genetic signal

Researchers studied over 22,000 people from Denmark to understand why schizophrenia affects people differently. They used artificial intelligence to find ten distinct groups within schizophrenia spectrum disorder based on clinical symptoms and genetic information. This discovery suggests that schizophrenia isn't one single disease but rather multiple related conditions with different genetic causes.

WHY IT MATTERSIf schizophrenia spectrum disorder can be divided into genetically distinct subtypes, future treatments could be personalized to match each person's specific genetic profile rather than using one-size-fits-all approaches.
Good to knowSchizophrenia Spectrum Disorder
ResearchRSSApr 22

Exposure to pesticide HCB may raise risk of ALS, new study finds

A new study from Denmark found that people with higher levels of HCB (a pesticide that was banned in many countries) in their blood may have a higher risk of developing ALS, a disease that affects nerve cells and causes muscle weakness. HCB was used as a pesticide in the past but is no longer allowed in many places because it can be harmful to health. This research suggests that exposure to this old pollutant might be connected to ALS risk.

WHY IT MATTERSIf you have ALS or a family history of it, understanding environmental risk factors like HCB exposure could help you and your doctor identify potential causes and discuss ways to reduce exposure to similar pollutants.
💬 Ask your doctoramyotrophic lateral sclerosis

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases